-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BB-1701 in Gastric Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BB-1701 in Gastric Cancer Drug Details:BB-1701 is under development for the treatment of HER2 positive solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BB-1701 in Colon Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BB-1701 in Colon CancerDrug Details:BB-1701 is under development for the treatment of HER2 positive solid tumors...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BB-1701 in Bladder Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BB-1701 in Bladder CancerDrug Details:BB-1701 is under development for the treatment of HER2 positive solid tumors...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BB-1701 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BB-1701 in Solid TumorDrug Details:BB-1701 is under development for the treatment of HER2 positive solid tumors...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BB-301 in Oculopharyngeal Muscular Dystrophy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BB-301 in Oculopharyngeal Muscular DystrophyDrug Details:BB-301 (Pabparna) is under development for the treatment of dysphagia associated...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BB-1701 in Gastroesophageal (GE) Junction Carcinomas
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BB-1701 in Gastroesophageal (GE) Junction Carcinomas Drug Details:BB-1701 is under development for the treatment of HER2...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BB-1701 in Metastatic Transitional (Urothelial) Tract Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BB-1701 in Metastatic Transitional (Urothelial) Tract CancerDrug Details:BB-1701 is under development for the treatment of HER2...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BB-1701 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BB-1701 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)Drug Details:BB-1701 is...
-
Product Insights
Mackay Council – BB Print Stadium Redevelopment – Queensland
Equip yourself with the essential tools needed to make informed and profitable decisions with our Mackay Council - BB Print Stadium Redevelopment - Queensland report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Diepholz – Syke BBS European School Building Renovation – Lower Saxony
Equip yourself with the essential tools needed to make informed and profitable decisions with our Diepholz - Syke BBS European School Building Renovation - Lower Saxony report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Major League Bb – Oakland to Jack London Square Gondola Line – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our Major League Bb - Oakland to Jack London Square Gondola Line - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
BBS Cap/ Galliard Homes/ Melburg Cap/ Redcatch Dev – Broadwalk Shopping Centre Redevelopment – Bristol
Equip yourself with the essential tools needed to make informed and profitable decisions with our BBS Cap/ Galliard Homes/ Melburg Cap/ Redcatch Dev - Broadwalk Shopping Centre Redevelopment - Bristol report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – P-12 in Burns
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.P-12 in Burns Drug Details:P-12 is under development for the prevention and treatment of burns. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SAR-443809 in Kidney Disease (Nephropathy)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.SAR-443809 in Kidney Disease (Nephropathy)Drug Details:SAR-443809 is under development for the treatment of rare renal diseases....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TERTiNT in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TERTiNT in Solid Tumor Drug Details: TERTiNT is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Wtint in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Wtint in Solid Tumor Drug Details: WTiNT is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Wtint in Glioblastoma Multiforme (GBM)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDataÂ’s proprietary machine learning algorithms developed using over 10 years of historical data. Wtint in Glioblastoma Multiforme (GBM) Drug Details: WTiNT is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Setmelanotide Hydrochloride Er in Obesity
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Setmelanotide Hydrochloride Er in Obesity Drug Details: Setmelanotide hydrochloride extended release formulation (CAM-4072) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EU-204 in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. EU-204 in Gastric Cancer Drug Details: EU-204 (EBViNT) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EU-204 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. EU-204 in Solid Tumor Drug Details: EU-204 (EBViNT) is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.